In June of this year, Leah Rosin, BPI’s marketing and digital content strategist, spoke with Rasmus Hother Le Fevre, managing director and corporate vice president, Novo Nordisk Pharmatech A/S (formerly FeF Chemicals A/S), about the company’s rebranding initiative. She began by asking him about the company’s history and reason for the name change to Novo Nordisk Pharmatech A/S.
Le Fevre:
Novo Nordisk Pharmatech was established in 1949 as FeF Chemicals, acquired by Novo Nordisk in 1986, and has been part of the company since then. On 1 September 2015, the company’s name was changed to Novo Nordisk Pharmatech. For the past 10 years, we have moved toward becoming a full-fledged pharmaceutical company and changed our product offerings, a transition that is finally completed. It was our wish to find a name that mirrors our focus and future aspirations. Our new name reflects the connection to our parent company, Novo Nordisk, and at the same time it reflects our business focus on the pharmaceutical and biophar...
